Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

CHA University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1999-01-01

Employees: -

Market Cap: -

Website: http://www.cha.ac.kr

Clinical Trials

The Influence of Infant Feeding Type on Preterm Infant's Intestinal Microbiome

Conditions: Microbial Colonization

First Posted Date: 2021-07-22

Last Posted Date: 2021-07-27

Lead Sponsor: CHA University

Target Recruit Count: 50

Registration Number: NCT04972214

Locations: 🇰🇷
CHA Bundang Medical center, Seongnam, Gyeonggi-do, Korea, Republic of

Changes in Shoulder Muscle Activation According to the Methods of Carrying Backpacks

Not Applicable

Conditions: Surface Emg
Shoulder Muscle Activation

Interventions: Diagnostic Test: surface EMG

First Posted Date: 2021-05-10

Last Posted Date: 2021-08-20

Lead Sponsor: CHA University

Target Recruit Count: 30

Registration Number: NCT04879901

Locations: 🇰🇷
Bundang CHA Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Recruiting

Conditions: Cholangiocarcinoma
Biliary Tract Cancer
Gallbladder Cancer

Interventions: Drug: nab-paclitaxel plus gemcitabine-cisplatin

First Posted Date: 2021-05-04

Last Posted Date: 2024-02-07

Lead Sponsor: CHA University

Target Recruit Count: 120

Registration Number: NCT04871321

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Completed

Conditions: Advanced Hepatocellular Carcinoma

Interventions: Drug: Atezolizumab plus bevacizumab

First Posted Date: 2021-04-28

Last Posted Date: 2023-03-23

Lead Sponsor: CHA University

Target Recruit Count: 124

Registration Number: NCT04862949

Locations: 🇰🇷
Cha Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost

Phase 4

Completed

Conditions: Glaucoma
Ocular Hypertension

Interventions: Drug: Monoprost
Drug: Xalatan

First Posted Date: 2021-02-08

Last Posted Date: 2021-02-08

Lead Sponsor: CHA University

Target Recruit Count: 57

Registration Number: NCT04743622

Locations: 🇰🇷
CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of

Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Glioblastoma Patients

Phase 1

Completed

Conditions: Neoplasms, Germ Cell and Embryonal
Recurrent Glioblastoma
Glioblastoma
Neoplasms, Brain
Adult Gliosarcoma

Interventions: Drug: MSC11FCD

First Posted Date: 2020-12-08

Last Posted Date: 2023-01-18

Lead Sponsor: CHA University

Target Recruit Count: 10

Registration Number: NCT04657315

Locations: 🇰🇷
Bundang CHA Medical Center, Seongnam, Kyunggido, Korea, Republic of

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

Phase 4

Conditions: Ocular Hypertensive
Glaucoma

Interventions: Drug: Brimonidine Tartrate 1.5mg

First Posted Date: 2020-12-01

Last Posted Date: 2020-12-01

Lead Sponsor: CHA University

Target Recruit Count: 61

Registration Number: NCT04647461

Locations: 🇰🇷
CHA University Bundang Medical Center, Seongnam, Bundang-gu, Korea, Republic of

Study of Entecavir for Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients

Conditions: Chronic Hepatitis B

First Posted Date: 2020-11-30

Last Posted Date: 2020-11-30

Lead Sponsor: CHA University

Target Recruit Count: 245

Registration Number: NCT04646928

Locations: 🇰🇷
Soon Chun Hyang University Hospital Bucheon, Bucheon, Korea, Republic of
🇰🇷
Soon Chun Hyang University Hospital Cheonan, Cheonan, Korea, Republic of
🇰🇷
Bundang Jesaeng Hospital, Gyeonggi-do, Korea, Republic of

and more 8 locations

Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)

Phase 2

Conditions: Gestational Trophoblastic Neoplasia

Interventions: Drug: Pembrolizumab Injection [Keytruda]

First Posted Date: 2020-03-11

Last Posted Date: 2020-03-11

Lead Sponsor: CHA University

Target Recruit Count: 15

Registration Number: NCT04303884

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Phase 1

Conditions: Dry Age Related Macular Degeneration

Interventions: Drug: SCNT-hES-RPE Cells

First Posted Date: 2017-10-09

Last Posted Date: 2017-10-09

Lead Sponsor: CHA University

Target Recruit Count: 3

Registration Number: NCT03305029

Locations: 🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy